Ardent Health Q3 revenue beats analyst estimates
Ardent Health Q3 revenue beats analyst estimates
Overview
U.S. hospital operator's Q3 revenue rose 3.1% yr/yr, beating analyst expectations
Adjusted EBITDA for Q3 beat analyst expectations
Company increased share repurchase authorization by $25 mln
Outlook
Company raises 2026 adjusted EBITDA guidance to $500–535 mln from $485–535 mln
Company maintains 2026 revenue outlook at $6.4–6.7 bln
Company lifts 2026 net income guidance to $132–167 mln from $110–163 mln
Result Drivers
COST SAVINGS INITIATIVES - IMPACT program contributed to efficiency gains and improved financial performance
VOLUME GROWTH - 2.9% rise in adjusted admissions drove revenue growth
Company press release: ID:nBw8gLDVSa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Beat | $1.62 bln | $1.60 bln (11 Analysts) |
Q3 EPS |
| $0.31 |
|
Q3 Net Income |
| $44.52 mln |
|
Q3 Adjusted EBITDA | Beat | $138 mln | $124.18 mln (11 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Ardent Health Inc is $13.00, about 11% above its November 3 closing price of $11.71
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago
Reuters Recommended Reads
Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats
Nov 4 - CVS to break up $117 billion business, separating pharmacies from insurance; shares fall
Nov 4 - India's Apollo Hospitals posts higher quarterly profit
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Ardent Health
See all newsArdent Health Inc reports results for the quarter ended September 30 - Earnings Summary
Ardent Health Q3 revenue beats analyst estimates
Brief: Ardent Health Inc Recharacterized Martin Bonick's Separation As Of Separation Date As A Termination For "Cause." - SEC Filing
Ardent Health Inc reports results for the quarter ended June 30 - Earnings Summary
Ardent Health Q2 hit by lower surgeries and admissions; cuts forecast